For your patients

Lung Foundation Australia has a range of evidence-based services and resources that will enable your patients to better understand and manage their condition. Our services and resources are designed to support clinical treatment plans and help drive optimal health outcomes.

Latest news

25 February 2021 – Centre of Research Excellence in Pulmonary Fibrosis (CRE-PF) Consensus Statement on COVID-19 Vaccination for Adults Living with Interstitial Lung Disease (ILD)

The CRE-PF COVID-19 Working Group is strongly supportive of the Australian Government rollout of Therapeutic Goods Administration (TGA) approved COVID-19 vaccines. This includes support of COVID-19 vaccination for adults living with interstitial lung disease who may be immunocompromised.